Compare weight-loss treatment options
Find the page that matches the question you have
Some pages compare two medicines. Others explain the difference between injections and tablets, NHS and private access, or the service around a provider. Start with the decision you are actually trying to make, then move into the more specific page if you need it.
Compare by medicine, route or service
These are the three comparison angles people use most often. Each one answers a slightly different question.
That keeps price, delivery and support in context rather than making the lowest first listing look like the whole answer.
Named treatment
For Mounjaro vs Wegovy, Orlistat vs Mysimba or Orlistat vs Xenical.
Treatment route
For injections, tablets, capsules, NHS access, private access or wider treatment families.
Provider service
For support, checks, delivery, restart rules, switching questions or ongoing cost.
Injections vs tablets is the clearest early comparison
If you are still early in your research, comparing injections with tablets helps separate the route, assessment and ongoing support questions before you open named provider pages.
- Injections usually raise dose steps, delivery handling and ongoing review questions.
- Tablets and capsules usually raise active ingredient, pack size and suitability questions.
- Provider support can still matter whichever treatment route you are researching.
The pages people open most often
Use these when you already know the main choice you want to understand.
Orlistat vs MysimbaTwo oral routes with different active ingredients and suitability questions.→
Orlistat vs XenicalGeneric and branded oral treatment compared side by side.→
NHS vs privateEligibility, timing and private-cost differences.→
Ozempic, Wegovy and Mounjaro in context
Ozempic is a common search term, so these pages keep the UK picture clear.
When the service matters as much as the medicine
Some choices come down to consultation style, delivery, repeat checks or how clearly the provider explains ongoing costs.
Switching providerPrevious-treatment evidence, dose continuity and reassessment questions.→
Restarting treatmentWhat may happen after a break, including updated checks or dose changes.→
Cost comparisonDose, pack size, delivery, repeat checks and ongoing support costs.→
Why similar options still feel different
Clinical fit
Active ingredient, treatment route, medical history and current medicines can shape whether a route is suitable.
Service fit
Assessment information, prescriber involvement, delivery and follow-up can vary between providers.
Access fit
NHS, private, clinic-led and programme-led routes answer different access questions and should not be judged only by speed or price.
Move on when you need more detail
If you still need more detail, the next pages add checks, delivery notes, how support is described and review dates.
Provider directoryOpen named provider pages for treatment coverage, checks and source dates.→
Safety checksReview legitimacy, registration, assessment quality and unsafe seller warning signs.→
Eligibility questionsUse the BMI tool and review common assessment questions.→
Route pages and provider pages work best together
The best comparisons usually keep treatment route, provider detail and current costs in view until the choice is clear.
High-intent route
Keep the clinic and treatment route connected
These hub pages are strongest when they keep readers moving between the clinic shortlist, provider evidence and treatment context instead of ending the journey too early.